Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-642 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
filingDate |
2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2003-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2003515567-A |
titleOfInvention |
Method for targeting cells expressing fibroblast growth receptor-3 or -2 |
abstract |
(57) [Summary]nFibroblast growth factor-18 (FGF-18) binds to FGF receptors-2 and -3. Compositions comprising FGF-18 components can be used to target cells that express those receptors. Suitable targets include tumor cells that constitutively express activated forms of FGF receptors-2 and 3. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010501531-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014088429-A |
priorityDate |
1999-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |